NAUT
NASDAQStockNautilus Biotechnology, Inc.
$2.35+0.07 (+2.84%)
52-Week Range
$0.64
$2.89
Key Stats
Market Cap
297.4M
P/E Ratio
—
Dividend Yield
—
Beta
1.36
Volume
122.3K
Avg Volume
205.2K
Performance
1M
+7.51%
3M
+20.53%
6M
+195.71%
YTD
+19.90%
1Y
+106.31%
3Y
+3.62%
5Y
-79.18%
Price Chart
ETF Exposure
NAUT is held by 11 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| VCNS.TO | Vanguard Conservative ETF Portfolio | 0.00% |
| VEQT.TO | Vanguard All-Equity ETF Portfolio | 0.00% |
| VRIF.TO | Vanguard Retirement Income ETF Portfolio | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
About NAUT ETF Exposure
Nautilus Biotechnology, Inc. (NAUT) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 297.4M, NAUT is a widely held institutional stock. The stock currently trades at $2.35. Investors can gain exposure to NAUT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NAUT, sorted by portfolio weight.